Fumihiko Sakai

6PUBLICATIONS
17CO-AUTHORS
Pacific Peoples health policyNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Traditional Chinese medicine and treatmentsWorkplace wellbeing and quality of working lifeEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 23, 2026
Local patient-centered headache advocacy with regional and global impact: lessons from the Japanese Patient Advocacy Coalition (JPAC).

Daisuke Danno, Eriko Yamanaka, Kaori Tabata

|Sep 22, 2022
Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial.

Yasuhiko Matsumori, Mika Komori, Yuka Tanji

|Oct 23, 2021
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study.

Fumihiko Sakai, Norihiro Suzuki, Xiaoping Ning

|Oct 01, 2021
Disability and Economic Loss Caused by Headache among Information Technology Workers in Korea.

Byung Kun Kim, Soo Jin Cho, Chang Soo Kim

|Jul 29, 2021
Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim

|Jul 29, 2021
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim

Pageof 1

Frequent Collaborators

3 joint publications

Norihiro Suzuki

3 joint publications

Byung-Kun Kim

3 joint publications

Nobuyuki Koga

2 joint publications

Takao Takeshima